Sector
PharmaceuticalsOpen
₹1,647.2Prev. Close
₹1,641.1Turnover(Lac.)
₹7,123.57Day's High
₹1,647.2Day's Low
₹1,62752 Week's High
₹2,03052 Week's Low
₹1,385.75Book Value
₹226.77Face Value
₹1Mkt Cap (₹ Cr.)
25,584.3P/E
39.21EPS
41.81Divi. Yield
0.943 Jul 2024
12:00 AM
AGM
Announcement Date: 03 Jul, 2024
4 Feb 2025
12:00 AM
Dividend
Dividend Amount: 8.5
Record Date: 08 Feb, 2025
29 Jun 2025
12:00 AM
Board Meeting
Agenda : Audited Result
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The inspection was conducted from March 10 to March 13 of 2025 at Plot No. 5, GIDC, Panoli, Gujarat facility.
EBITDA at the operating level jumped 14.1% to ₹254.5 crore from ₹223.1 crore in the same quarter last year.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 15.52 | 15.51 | 15.46 | 15.46 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,870.74 | 2,426.98 | 2,088.21 | 1,791 |
Net Worth | 2,886.26 | 2,442.49 | 2,103.67 | 1,806.46 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 2,189.87 | 1,891.99 | 1,640.74 | 1,250.13 |
yoy growth (%) | 15.74 | 15.31 | 31.24 | 6.42 |
Raw materials | -743.69 | -625.75 | -569.13 | -479.67 |
As % of sales | 33.96 | 33.07 | 34.68 | 38.36 |
Employee costs | -399.06 | -305.97 | -293.78 | -217.3 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 471.29 | 593.7 | 349.56 | 179.04 |
Depreciation | -71.28 | -67.35 | -65.09 | -55.94 |
Tax paid | -110.29 | -146.62 | -71.41 | -51.04 |
Working capital | 298.14 | 110.36 | 28.72 | 67.62 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 15.74 | 15.31 | 31.24 | 6.42 |
Op profit growth | -7.84 | 49.09 | 85.51 | -10.11 |
EBIT growth | -20.74 | 70.46 | 93.19 | -17.73 |
Net profit growth | -19.25 | 66.73 | 109.48 | -25.99 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 3,917.99 | 3,484.18 | 3,149.28 | 2,424.24 | 2,042.52 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,917.99 | 3,484.18 | 3,149.28 | 2,424.24 | 2,042.52 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 38.32 | 37.27 | 9.94 | 39.23 | 112.38 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,677.5 | 94 | 4,02,584.41 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,859.5 | 82.46 | 1,82,147.28 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,497.6 | 25.13 | 1,20,934.05 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,349.4 | 59.47 | 1,13,319.98 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.8 | 19.84 | 1,06,137.94 | 1,200.7 | 0.63 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non-Exec. & Independent Dir.
Padmini Khare Kaicker
Non-Exec. & Independent Dir.
Sumit Bose
Non-Exec & Non-Independent Dir
Prashant Kumar.
Whole Time Director & CEO
Nikhil Chopra
Company Sec. & Compli. Officer
SANDEEP PHADNIS
Chairman & Independent Directo
Arun Duggal
Non Executive Director
GAURAV TREHAN
Non Executive Director
Akshay Tanna
Additional Director
Ashwani Puri
Neelam Centre 4th Floor,
B-Wing Hind Cycle Road Worli,
Maharashtra - 400030
Tel: 91-022-2482 2222/2493 0918
Website: http://www.jbpharma.com
Email: investorelations@jbpharma.com; secretarial@jbpharm
Plot No B-5 MIDC,
Part B Cross Lane, Marol Andheri(E),
Mumbai-400093
Tel: 91-22-6671 2151
Website: www.dfssl.com
Email: marketing@dfssl.com/investorsqry@dfssl.com
Summary
J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976. The Company is engaged i...
Read More
Reports by J B Chemicals & Pharmaceuticals Ltd
What is the J B Chemicals & Pharmaceuticals Ltd share price today?
What is the Market Cap of J B Chemicals & Pharmaceuticals Ltd?
What is the PE and PB ratio of J B Chemicals & Pharmaceuticals Ltd?
What is the 52 Week High and Low of J B Chemicals & Pharmaceuticals Ltd?
What is the CAGR of J B Chemicals & Pharmaceuticals Ltd?
What is the shareholding pattern of J B Chemicals & Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
